Page 181 - SHB 2020 Issue 1
P. 181

Profile’s Stock Exchange Handbook: 2020 – Issue 1                       JSE – MED
                                                  PER SHARE STATISTICS (cents per share)
             Mediclinic International plc         EPS (ZARc)   270.54  - 369.21 - 1 148.57  570.71  613.61
        MED                                       HEPS-C (ZARc)  259.58  515.09  475.27  570.71  613.61
       ISIN: GB00B8HX8Z88
       SHORT: MEDICLINIC                            Pct chng p.a.  0.8  8.4  - 16.7  - 7.0  26.8
       CODE: MEI                                    Tr 5yr av grwth %  -  5.7  79.3  46.0  47.0
       REG NO: 08338604                           DPS (ZARc)    60.83  145.41  139.39  133.92  155.52
       FOUNDED: 1983                                Pct chng p.a.  -   4.3  4.1  - 13.9  46.0
       LISTED: 1986                                 Tr 5yr av grwth %  -  10.3  11.8  13.0  17.1
                                                  NAV PS (ZARc)  8 421.92 8 372.73 7 581.02 9 277.81 10 095.11
        NATURE OF BUSINESS:                       3 Yr Beta     1.13  1.19  0.98  1.38  0.94
        Mediclinic is an international private healthcare services  Price High  6 806  12 023  15 261  21 803  20 870
        group with operating divisions in  Switzerland, Southern  Price Low  5 268  5 199  8 810  11 384  9 050
        Africa (South  Africa and Namibia)  and the United Arab  Price Prd End  6 165  5 699  10 015  11 918  18 976
        Emirates. Its core purpose is to enhance the quality of life of  RATIOS
        patients by providing com pre hen sive high-quality healthcare  Ret on SH Fnd  7.07  - 3.98  - 14.05  5.84  5.32
        services in such a way that the Group will be regarded as the  Ret On Tot Ass  3.90  - 2.02  - 7.47  3.27  2.90
        most respected and trusted provider of healthcare services by  Oper Pft Mgn  9.83  2.76  - 10.01  13.17  13.67
                                                                      0.53
                                                                            0.50
                                                                                       0.40
                                                  D:E
                                                                                 0.40
                                                                0.98
        patients, doctors and funders  of healthcare in each  of its  Int Cover  3.73  n/a  n/a  5.40  5.88
        markets. Mediclinic also holds a 29.9% interest in Spire  Current Ratio  1.83  1.86  1.83  1.81  1.18
        Healthcare Group plc, an LSE-listed and UK-based private  Div Cover  4.45  - 2.20  - 8.17  3.92  3.95
        healthcare group.                                     NUMBER OF EMPLOYEES: 32 398
        Mediclinic comprises 77 hospitals, five sub-acute hospitals, 13  DIRECTORS: Hertzog Dr Edwin de la H (Chair, ne),
        day case clinics and 22 out pa tient clinics. Hirslanden operates  van der Merwe Dr C A (CEO), Myburgh P J (CFO),
        17 hospitals, two day case clinics and three out pa tient clinics in  Al Hashimi Dr M Y (ind ne), Durand J J (ne),
                                                               Grieve J A (snr ind ne, UK),
        Swit zer land with more than 1 900 inpatient beds; Mediclinic  Harvey Dr F A H (ind ne, UK),
        Southern Africa operates 53 hospitals, five sub-acute hospitals  Keating S D (ind ne, Ire), Meintjes D P (ne),
        and 9 day case clinics with more than 8 500 inpatient beds; and  Oswald Dr A (ind ne, Swiss), Petersen T D (ind ne),
                                                               Singer T (ind ne), Uys P J (alt)
        Mediclinic Middle East operates seven hospitals, two day case  POPULAR BRAND NAMES: ER24, Hirslanden,
        clinics and 19 out pa tient clinics with more than 900 inpatient  Scan the QR code to  Medical Innovations, Mediclinic, Mediclinic Middle
                                                   visit our website
        beds in the United Arab Emirates.                      East, MHR
        Mediclinic has a primary listing on the Main Market of the LSE  POSTAL ADDRESS: PO Box 456, Stellenbosch, 7599
        in the United Kingdom, with secondary listings on the JSE in  EMAIL: info@mediclinic.com
        South Africa and the NSX in Namibia.      WEBSITE: www.mediclinic.com  FAX: 086-532-2557
                                                  TELE PHONE: 021-809-6500
        Mediclinic is as so ci ated with the following companies/in sti -  COMPANY SECRETARY: Link Company Matters
        tu tions:                                 TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
        Southern Africa                           SPONSORS: Morgan Stanley & Co International plc (UK), Rand Merchant
        *Mediclinic Southern Africa -  private healthcare group  in  Bank (A division of FirstRand Bank Ltd. (SA)), Simonis Storm (Pty) Ltd.
                                                   (Nam), UBS Investment Bank (UK)
        South Africa and Namibia                  AUDITORS: PwC LLP
        *Medical In no va tions - group pro cure ment and man u fac turer
        of hospital equipment in South Africa     CALENDAR               Expected     Status
        *MHR - re cruit ment of temporary and permanent staff across  Next Final Results  21 May 2020  Con firmed
        all sectors of the healthcare industry    Annual General Meeting  22 Jul 2020  Con firmed
        *ER24 - emergency medical services in South Africa  Next Interim Results  Nov 2020  Un con firmed
        Swit zer land
        *Hirslanden - private healthcare group in Swit zer land  CAPITAL STRUCTURE  AUTHORISED  ISSUED
        United Arab Emirates                      MEI  Ords 10p ea            -    737 243 810
        *Mediclinic Middle East - private healthcare group in the  DISTRIBUTIONS [GBPp]
        United Arab Emirates                      Ords 10p ea           Ldt     Pay    Amt
        United Kingdom                            Interim No  13     3 Dec 19  17 Dec 19  3.20
        *Spire Healthcare - private healthcare group in the United  Final No  12  11 Jun 19  29 Jul 19  4.70
        Kingdom and listed on the LSE             Interim No  11     4 Dec 18  18 Dec 18  3.20
                                                  Final No  10       12 Jun 18  30 Jul 18  4.70
       SECTOR: Health—Health—Health Equip&Srvcs—Health Providers  LIQUIDITY: Nov19 Ave 5m shares p.w., R360.2m(36.9% p.a.)
       MAJOR ORDINARY SHAREHOLDERS as at 01 Jul 2019
         Remgro                           44.56%          HEES       40  Week  MA  MEDICLINIC
         Genesis Investment Management LLP  9.50%                                      21091
         Public Investment Corporation SOC Ltd.  6.21%
       NOTES: The Group’s func tional currency changed from the South African          17718
        rand in 2015 to pound sterling in 2016.
                                                                                       14345
       FINANCIAL STATISTICS
       (GBP million)  Sep 19  Mar 19  Mar 18  Mar 17  Mar 16
                   Interim  Final  Final  Final  Final                                 10972
       Turnover      1 515  2 932  2 876  2 749  2 107                                 7600
       Op Inc         149   81  - 288  362  288
       NetIntPd(Rcvd)  40   57    85   67    49                                        4227
       Tax            - 11  - 7   - 5  64    55      2014  |  2015  |  2016  |  2017  |  2018  |  2019
       Minority Int   13    21    18   14    13   Recent Announcements
       Att Inc        109  - 151  - 492  229  177  Mediclinic interim results September 2019 - Thursday, 14 November
       TotCompIncLoss  271  - 22  - 723  665  228
       Hline Erngs-CO  105  211  203   229  177    2019: Revenue for the interim period increased to GBP1.515
       Fixed Ass     4 386  3 524  3 590  3 703  3 199  billion (2018: GBP1.390 billion) and operating profit shot up to
       Inv in Assoc   193  193   357   465  455    GBP149 million (2018: GBP39 million). Profit for the period at -
       Inv & Loans    10    10    7     8     6    tributable to equity holders of the company recovered to
       Def Tax Asset  31    23    22   21    16    GBP109 million (2018: loss of GBP168 million). In addition,
       Tot Curr Ass  1 075  1 091  961  1 069  931
       Ord SH Int    3 331  3 151  3 286  4 086  3 509  headline earnings per share improved to GBP14.2 pence per
       Minority Int   118  115    87   78    61    share (2018: GBP10.7 pence per share).
       LT Liab       3 312  2 577  2 445  2 668  2 192
       Tot Curr Liab  586  584   525   590  787
                                               177
   176   177   178   179   180   181   182   183   184   185   186